Search Results - "Tal-Singer, Ruth"

Treatment decisions: insights from people with asthma or COPD and their healthcare providers on disease and treatment decisions.

Authors: Tal-Singer, Ruth Román-Rodríguez, Miguel McMullan, Ilona et al.

Source: Patient Preference & Adherence. Jun2025, Vol. 19, p1583-1591. 9p.

Disease Impact and Perception of Biologics in Adults with Type 2 Inflammation Respiratory Disease: International Survey Results.

Authors: Tal-Singer, Ruth Willard, Kristen S Luttmann, Mark A et al.

Source: Patient Preference & Adherence. Apr2025, Vol. 18, p1159-1170. 12p.

Safety and efficacy of astegolimab for COPD with frequent exacerbations regardless of baseline blood eosinophil counts (ALIENTO and ARNASA): randomised, double-blind, placebo-controlled, phase 2b and 3 trials.

Authors: Papi, Alberto Greening, Neil J Bhatt, Surya P et al.

Source: Lancet. May2026, Vol. 407 Issue 10543, p2027-2039. 13p.

Subjects: Chronic obstructive pulmonary disease, Disease exacerbation, Monoclonal antibodies, Patient safety, Interleukin-33, Clinical trials

Attitudes toward vaccines and antivirals for viral respiratory infections in a survey of US adults with chronic health conditions.

Authors: Tal-Singer, Ruth McCreary, Gretchen Luttmann, Mark et al.

Source: Vaccine. Apr2026, Vol. 77, pN.PAG-N.PAG. 1p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Fluticasone Propionate Protects against Ozone-Induced Airway Inflammation and Modified Immune Cell Activation Markers in Healthy Volunteers.

Authors: Alexis, Neil E. Lay, John C. Haczku, Angela et al.

Source: Environmental Health Perspectives. Jun2008, Vol. 116 Issue 6, p799-805. 7p. 1 Diagram, 2 Charts, 3 Graphs.

Subject Terms: *Physiological effects of ozone, *Biomarkers, Adrenocortical hormones, Asthma treatment, Inhalers, Immunology of inflammation, Sputum examination, Neutrophils

Chronic obstructive pulmonary disease and inhaled steroids alter surfactant protein D (SP-D) levels: a cross-sectional study.

Authors: Sims, Michael W. Tal-Singer, Ruth M. Kierstein, Sonja et al.

Source: Respiratory Research. 2008, Vol. 9, Special section p1-9. 9p. 3 Charts, 2 Graphs.

Patient and Caregiver Perceptions on Education and Treatment Needs in Atopic Dermatitis from an International Survey.

Authors: Willard, Kristen Novak, Špela Lio, Peter A. et al.

Source: Dermatology & Therapy. Jan2026, Vol. 16 Issue 1, p391-403. 13p.

Identifying Physical Activity Profiles in COPD Patients Using Topic Models.

Authors: Spina, Gabriele Casale, Pierluigi Albert, Paul S. et al.

Source: IEEE Journal of Biomedical & Health Informatics; Sep2015, Vol. 19 Issue 5, p1567-1576, 10p

Long‐term trends of COPD mortality: Gaps and opportunities.

Authors: Mannino, David M. Tal‐Singer, Ruth

Source: Respirology. Nov2022, Vol. 27 Issue 11, p914-915. 2p.

The Responsiveness of Exercise Tests in COPD: A Randomized Controlled Trial.

Authors: Harvey-Dunstan, Theresa C. Baldwin, Molly M. Tal-Singer, Ruth et al.

Source: CHEST. Jan2025, Vol. 167 Issue 1, p98-111. 14p.

Lessons from ECLIPSE: a review of COPD biomarkers.

Authors: Faner, Rosa Tal-Singer, Ruth Riley, John H. et al.

Source: Thorax. Jul2014, Vol. 69 Issue 7, p666-672. 7p. 2 Charts.

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Inhaled Doses of Umeclidinium in Healthy Subjects: Two Randomized Studies.

Authors: Cahn, Anthony Tal-Singer, Ruth Pouliquen, Isabelle et al.

Source: Clinical Drug Investigation. 2013, Vol. 33 Issue 7, p477-488. 12p. 4 Charts, 3 Graphs.

Initial assessment of single and repeat doses of inhaled umeclidinium in patients with chronic obstructive pulmonary disease: Two randomised studies

Authors: Tal-Singer, Ruth Cahn, Anthony Mehta, Rashmi et al.

Source: European Journal of Pharmacology. Feb2013, Vol. 701 Issue 1-3, p40-48. 9p.

Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease: A Large Case-Controlled Study.

Authors: Fisk, Marie Mceniery, Carmel M. Gale, Nichola et al.

Source: Hypertension (0194911X). Mar2018, Vol. 71 Issue 3, p499-506.

Perspectives on Treatment Decisions, Preferences, and Adherence and Long-Term Management in Asthma and COPD: A Qualitative Analysis of Patient, Caregiver, and Healthcare Provider Insights.

Authors: Román-Rodríguez, Miguel McMullan, Ilona Warner, Michelle et al.

Source: Patient Preference & Adherence. Nov2024, Vol. 18, p2295-2306. 12p.

Gene expression changes caused by the p38 MAPK inhibitor dilmapimod in COPD patients: analysis of blood and sputum samples from a randomized, placebo-controlled clinical trial.

Authors: Betts, Joanna C. Mayer, Ruth J. Tal ‐ Singer, Ruth et al.

Source: Pharmacology Research & Perspectives. Feb2015, Vol. 3 Issue 1, pn/a-N.PAG. 10p.

Altered Gene Expression in Blood and Sputum in COPD Frequent Exacerbators in the ECLIPSE Cohort.

Authors: Singh, Dave Fox, Steven M. Tal-Singer, Ruth et al.

Source: PLoS ONE. Sep2014, Vol. 9 Issue 9, p1-9. 9p.